Phase II Study of Ceralasertib (AZD6738) in Combination with Durvalumab in Patients with Advanced/metastatic Melanoma Who Have Failed Prior Anti-Pd-1 Therapy
Journal of Clinical Oncology（2021）
关键词
ataxia telangiectasia and Rad3 related protein (ATR),melanoma,durvalumab,ceralasertib,immune resistance
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要